Between the Bells

Between the Bells is a market commentary and executive interview show for investors following Australian markets and macro signals. It works in a practical register. The episodes are built around what changed, why it matters, and how it may affect portfolios or listed companies. Recent weekly wrap coverage has focused on fast market rallies, conflict-driven supply shocks, higher energy prices, inflation expectations, and the US Fed's easing bias. The analysis does not linger on slogans. It pushes into scenarios, earnings risk, sector rotation, and the difference between short, sharp market reactions and more durable economic consequences. The From the Helm episodes add a different rhythm. Sophia Mavridis speaks with company leaders about strategy, customer traction, technology, commercial progress, and upcoming milestones. Artrya Limited's conversation centers on coronary artery disease assessment, FDA-cleared platforms, US hospital customers, and the Sapphire project. Bell Financial Group's episode looks at the shift from transaction-heavy revenue toward broader wealth management, recurring revenue, digital interfaces, and AI-era trust. Healthcare coverage with Grady Wolfe, Dr. Chris Burns, and Thomas Wakeham brings drug development into investor language, including pancreatic cancer, Namofotinib, phase two data, FDA alignment, and commercialisation. The Market Insights strand broadens the lens again. Commodities conversations with Hedley Wittup examine gold's strength, copper exposure, producers such as Evolution, and how large miners fit into the current cycle. The show is especially useful when it connects company claims to measurable signals: customers, approvals, trial data, scan volumes, revenue mix, cash balances, and cost structures. It assumes the listener is comfortable with markets. It also rewards that attention with dense, current, decision-oriented context. Between the Bells is not a beginner's explainer. It is a working investor's briefing desk, switching between macro pressure, sector detail, and boardroom strategy.